Business
Germany recommends against giving Oxford-AstraZeneca vaccine to over 65s – Sydney Morning Herald
The country’s vaccine committee says there is not enough trial data available for the age group. Australia says it trusts the TGA’s assessment.
The experts endorsed the vaccines rollout for people aged 18 to 64.
The European Unions drug regulator, the European Medicines Agency, will hand down its verdict on the vaccine on Friday.
Australia has rights to 53.8 million doses of the vaccine developed by AstraZeneca and the University of Oxford, representing the bulk of its initial portfolio.
The Australian Therapeutic Goods Administration has also been scrutinising AstraZenecas trial data ahead of an expected decision in February on whether…
-
General24 hours agoLive and dead animals seized from Kyneton business after investigation
-
General18 hours agoIran’s currency at record low as tensions run high
-
Noosa News24 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoHundreds pack neighbourhood for no-reserve auction of ready-made charity home